“Proteomics International Laboratories Ltd managing director Dr Richard Lipscombe introduces Proactive to its work in diagnostics, specifically in the area of precision medicine. Lipscombe highlights the three biomarkers for Diabetic Kidney Disease identified by the company’s Promarker™ Platform and which have been verified, validated and developed into a commercially available test: PromarkerD.”
Article: Proteomics International Laboratories set to expand its commercial footprint in the US
